دورية أكاديمية

GVHD like skin eruption post-autologous stem cell transplantation.

التفاصيل البيبلوغرافية
العنوان: GVHD like skin eruption post-autologous stem cell transplantation.
المؤلفون: Fraebel J; Division of Hematology/Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA., Park S; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Department of Hematology, Catholic Hematology Hospital, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea., Shah R; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA., Prieto-Granada C; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA., Mason EF; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA., Sengsayadeth S; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Vanderbilt-Ingram Cancer Center (VICC), Nashville, TN, 37232, USA.; Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN, 37232, USA., Chinratanalab W; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Vanderbilt-Ingram Cancer Center (VICC), Nashville, TN, 37232, USA.; Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN, 37232, USA., Savani B; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Vanderbilt-Ingram Cancer Center (VICC), Nashville, TN, 37232, USA.; Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN, 37232, USA., Jayani RV; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Vanderbilt-Ingram Cancer Center (VICC), Nashville, TN, 37232, USA., Kassim A; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Vanderbilt-Ingram Cancer Center (VICC), Nashville, TN, 37232, USA.; Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN, 37232, USA., Dholaria BR; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA.; Vanderbilt-Ingram Cancer Center (VICC), Nashville, TN, 37232, USA.; Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN, 37232, USA., Kim TK; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. tae.k.kim@vumc.org.; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, 37232, USA. tae.k.kim@vumc.org.; Vanderbilt-Ingram Cancer Center (VICC), Nashville, TN, 37232, USA. tae.k.kim@vumc.org.; Veterans Affairs Medical Center, Tennessee Valley Healthcare System, Nashville, TN, 37232, USA. tae.k.kim@vumc.org.
المصدر: Bone marrow transplantation [Bone Marrow Transplant] 2024 Jun; Vol. 59 (6), pp. 900-903. Date of Electronic Publication: 2024 Mar 11.
نوع المنشور: Case Reports; Letter; Journal Article
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE
أسماء مطبوعة: Publication: <2003->: London : Nature Publishing Group
Original Publication: Basingstoke, Hampshire : Scientific & Medical Division, Macmillan Press, c1986-
مواضيع طبية MeSH: Graft vs Host Disease*/etiology , Hematopoietic Stem Cell Transplantation*/adverse effects , Hematopoietic Stem Cell Transplantation*/methods, Humans ; Male ; Transplantation, Autologous ; Middle Aged ; Female
References: Thein SL, Goldman JM, Galton DA. Acute ‘graft-versus-host disease’ after autografting for chronic granulocytic leukemia in transformation. Ann Intern Med. 1981;94:210–1. (PMID: 10.7326/0003-4819-94-2-2106937154)
Rappeport J, Mihm M, Reinherz E, Lopansri S, Parkman R. Acute graft-versus-host disease in recipients of bone-marrow transplants from identical twin donors. Lancet. 1979;2:717–20. (PMID: 10.1016/S0140-6736(79)90644-590805)
Otegbeye F, Gale RP, Lazarus HM. Autologous GVHD? Bone Marrow Transpl. 2014;49:1349–51. (PMID: 10.1038/bmt.2014.169)
Glazier A, Tutschka PJ, Farmer ER, Santos GW. Graft-versus-host disease in cyclosporin A-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med. 1983;158:1–8. (PMID: 10.1084/jem.158.1.16345713)
Janeczko-Czarnecka M, Rybka B, Ryczan-Krawczyk R, KaŁwak K, Ussowicz M. Thymic activity in immune recovery after allogeneic hematopoietic stem cell transplantation in children. Cent Eur J Immunol. 2020;45:151–9. (PMID: 10.5114/ceji.2019.89843334563257792432)
van den Brink MRM, Velardi E, Perales M-A. Immune reconstitution following stem cell transplantation. Hematology. 2015;2015:215–9. (PMID: 10.1182/asheducation-2015.1.21526637724)
Nishimura H, Nose M, Hiai H, Minato N, Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity. 1999;11:141–51. (PMID: 10.1016/S1074-7613(00)80089-810485649)
Francisco LM, Sage PT, Sharpe AH. The PD-1 pathway in tolerance and autoimmunity. Immunol Rev. 2010;236:219–42. (PMID: 10.1111/j.1600-065X.2010.00923.x206368202919275)
Schilbach K, Schick J, Wehrmann M, Wollny G, Simon P, Schlegel PG, et al. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine GVHD across minor histocompatibility antigen barriers. Transplantation. 2007;84:214–22. (PMID: 10.1097/01.tp.0000268074.77929.5417667813)
Merryman RW, Castagna L, Giordano L, Ho VT, Corradini P, Guidetti A, et al. Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma. Leukemia. 2021;35:2672–83. (PMID: 10.1038/s41375-021-01193-633658659)
Cornell RF, Hari P, Drobyski WR. Engraftment syndrome after autologous stem cell transplantation: an update unifying the definition and management approach. Biol Blood Marrow Transpl. 2015;21:2061–8. (PMID: 10.1016/j.bbmt.2015.08.030)
Holmberg L, Kikuchi K, Gooley TA, Adams KM, Hockenbery DM, Flowers MED et al. Gastrointestinal graft-versus-host disease in recipients of autologous hematopoietic stem cells: incidence, risk factors, and outcome. Biol Blood Marrow Transplant. 2006;12:226–34.
Saunders MD, Shulman HM, Murakami CS, Chauncey TR, Bensinger WI, McDonald GB. Bile duct apoptosis and cholestasis resembling acute graft-versus-host disease after autologous hematopoietic cell transplantation. Am J Surg Pathol. 2000;24:1004–8.
Cogbill CH, Drobyski WR, Komorowski RA. Gastrointestinal pathology of autologous graft-versus-host disease following hematopoietic stem cell transplantation: a clinicopathological study of 17 cases. Mod Pathol Off J U S Can Acad Pathol Inc. 2011;24:117–25.
Lazarus HM, Sommers SR, Arfons LM, Fu P, Ataergin SA, Kaye NM et al. Spontaneous autologous graft-versushost disease in plasma cell myeloma autograft recipients: flow cytometric analysis of hematopoietic progenitor cell grafts. Biol Blood Marrow Transplant. 2011;17:970–8.
Zenz T, Ritgen M, Dreger P, Kröber A, Barth TF, Schlenk R et al. Autologous graft-versus-host disease-like syndrome after an alemtuzumab-containing conditioning regimen and autologous stem cell transplantation for chronic lymphocytic leukemia. Blood 2006;108:2127–30.
Baron F, Gothot A, Salmon JP, Hermanne JP, Pierard GE, Fillet G et al. Clinical course and predictive factors for cyclosporin-induced autologous graft-versus-host disease after autologous haematopoietic stem cell transplantation. Br J Haematol 2000;111:745–53.
معلومات مُعتمدة: CSDG-18-198-01-LIB American Cancer Society (American Cancer Society, Inc.); IRG-22-145-62-04 American Cancer Society (American Cancer Society, Inc.)
تواريخ الأحداث: Date Created: 20240312 Date Completed: 20240607 Latest Revision: 20240621
رمز التحديث: 20240622
DOI: 10.1038/s41409-024-02259-6
PMID: 38467749
قاعدة البيانات: MEDLINE